+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Atherectomy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5987799
Free Webex Call
10% Free customization

Directional is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Atherectomy Devices Market, valued at USD 1.12 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 1.69 Billion by 2030. Atherectomy devices are specialized medical instruments employed in minimally invasive endovascular procedures to mechanically remove atherosclerotic plaque from blood vessel walls, thereby restoring adequate blood flow. This market's growth is primarily driven by the escalating global prevalence of cardiovascular diseases, particularly peripheral artery disease and coronary artery disease. Concurrently, the increasing aging demographic, which exhibits higher susceptibility to vascular conditions, further fuels demand. The rising preference for minimally invasive treatment modalities, offering reduced recovery times and fewer complications, also significantly contributes to market expansion.

Key Market Drivers

The escalating burden of cardiovascular diseases directly translates into a greater patient pool requiring intervention, including atherectomy procedures. Atherosclerosis, a primary cause of conditions such as peripheral artery disease and coronary artery disease, necessitates mechanical plaque removal to restore blood flow and prevent severe complications. According to the Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators, in their "Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023" published in *JACC* in September 2025, there were 626 million prevalent cases of cardiovascular disease globally in 2023. This highlights the extensive and current need for effective treatment modalities.

Key Market Challenges

The elevated cost of atherectomy devices presents a substantial impediment to the growth of the global market. This financial barrier directly affects the accessibility and widespread adoption of these advanced interventional tools within diverse healthcare systems. High procurement costs can strain hospital budgets, particularly in regions with limited healthcare spending, thereby restricting the acquisition and availability of atherectomy technology. This limitation directly impacts the volume of procedures that can be performed, slowing market penetration and expansion.

Key Market Trends

The rising adoption of combination therapies that integrate atherectomy with drug-coated balloons (DCBs) is emerging as a key trend shaping the interventional cardiology and vascular treatment landscape. This combined approach is designed to optimise procedural outcomes by mechanically removing plaque through atherectomy, followed by targeted local drug delivery to reduce the risk of restenosis, thereby offering a more comprehensive treatment solution for complex vascular lesions. Clinicians are increasingly acknowledging the clinical value of this synergistic strategy, particularly in improving long-term vessel patency and minimising the need for repeat interventions.

Key Market Players Profiled:

  • Braun Melsungen AG
  • Abbott Laboratories, Inc.
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Medtronic plc
  • Becton, Dickinson, and Company
  • Terumo Corporation
  • Cardinal Health Inc.
  • AngioDynamics Inc.
  • Avinger Inc.

Report Scope:

In this report, the Global Atherectomy Devices Market has been segmented into the following categories:

By Product:

  • Directional
  • Rotational
  • Laser
  • Orbital

By Application:

  • Peripheral
  • Cardiovascular
  • Neurovascular

By End User:

  • Hospitals & Surgical Centres
  • Ambulatory Care Centres
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Atherectomy Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Atherectomy Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Directional, Rotational, Laser, Orbital)
5.2.2. By Application (Peripheral, Cardiovascular, Neurovascular)
5.2.3. By End User (Hospitals & Surgical Centres, Ambulatory Care Centres, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Atherectomy Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Atherectomy Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Atherectomy Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Atherectomy Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Atherectomy Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Atherectomy Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. France Atherectomy Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Atherectomy Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Atherectomy Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Atherectomy Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Atherectomy Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Atherectomy Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Atherectomy Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Atherectomy Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Atherectomy Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Atherectomy Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Middle East & Africa Atherectomy Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Atherectomy Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. UAE Atherectomy Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. South Africa Atherectomy Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. South America Atherectomy Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Atherectomy Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Colombia Atherectomy Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Argentina Atherectomy Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Atherectomy Devices Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Braun Melsungen AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Abbott Laboratories, Inc.
15.3. Koninklijke Philips N.V.
15.4. Boston Scientific Corporation
15.5. Medtronic plc
15.6. Becton, Dickinson, and Company
15.7. Terumo Corporation
15.8. Cardinal Health Inc.
15.9. AngioDynamics Inc.
15.10. Avinger Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Atherectomy Devices market report include:
  • Braun Melsungen AG
  • Abbott Laboratories, Inc.
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Medtronic plc
  • Becton, Dickinson, and Company
  • Terumo Corporation
  • Cardinal Health Inc.
  • AngioDynamics Inc.
  • Avinger Inc.

Table Information